Literature DB >> 9687506

PACT, a protein activator of the interferon-induced protein kinase, PKR.

R C Patel1, G C Sen.   

Abstract

PKR, a latent protein kinase, mediates the antiviral actions of interferon. It is also involved in cellular signal transduction, apoptosis, growth regulation and differentiation. Although in virus-infected cells, viral double-stranded (ds) RNA can serve as a PKR activator, cellular activators have remained obscure. Here, we report the cloning of PACT, a cellular protein activator of PKR. PACT heterodimerized with PKR and activated it in vitro in the absence of dsRNA. In mammalian cells, overexpression of PACT caused PKR activation and, in yeast, co-expression of PACT enhanced the anti-growth effect of PKR. Thus, PACT has the hallmarks of a direct activator of PKR.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9687506      PMCID: PMC1170771          DOI: 10.1093/emboj/17.15.4379

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  72 in total

1.  The phosphorylation state of eucaryotic initiation factor 2 alters translational efficiency of specific mRNAs.

Authors:  R J Kaufman; M V Davies; V K Pathak; J W Hershey
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

Review 2.  The eIF-2alpha kinases and the control of protein synthesis.

Authors:  C de Haro; R Méndez; J Santoyo
Journal:  FASEB J       Date:  1996-10       Impact factor: 5.191

3.  Specific mutations near the amino terminus of double-stranded RNA-dependent protein kinase (PKR) differentially affect its double-stranded RNA binding and dimerization properties.

Authors:  R C Patel; P Stanton; G C Sen
Journal:  J Biol Chem       Date:  1996-10-11       Impact factor: 5.157

4.  An essential role for the interferon-inducible, double-stranded RNA-activated protein kinase PKR in the tumor necrosis factor-induced apoptosis in U937 cells.

Authors:  M C Yeung; J Liu; A S Lau
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

5.  Double-stranded (ds) RNA binding and not dimerization correlates with the activation of the dsRNA-dependent protein kinase (PKR).

Authors:  S Wu; R J Kaufman
Journal:  J Biol Chem       Date:  1996-01-19       Impact factor: 5.157

6.  A testis cytoplasmic RNA-binding protein that has the properties of a translational repressor.

Authors:  K Lee; M A Fajardo; R E Braun
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

7.  Autophosphorylation of the protein kinase dependent on double-stranded RNA.

Authors:  J Galabru; A Hovanessian
Journal:  J Biol Chem       Date:  1987-11-15       Impact factor: 5.157

8.  Mechanism of interferon action. Biochemical and genetic evidence for the intermolecular association of the RNA-dependent protein kinase PKR from human cells.

Authors:  L G Ortega; M D McCotter; G L Henry; S J McCormack; D C Thomis; C E Samuel
Journal:  Virology       Date:  1996-01-01       Impact factor: 3.616

9.  Double-stranded-RNA-dependent protein kinase and TAR RNA-binding protein form homo- and heterodimers in vivo.

Authors:  G P Cosentino; S Venkatesan; F C Serluca; S R Green; M B Mathews; N Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

10.  Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase.

Authors:  Y L Yang; L F Reis; J Pavlovic; A Aguzzi; R Schäfer; A Kumar; B R Williams; M Aguet; C Weissmann
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

View more
  171 in total

Review 1.  Translational control of viral gene expression in eukaryotes.

Authors:  M Gale; S L Tan; M G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

2.  Modular structure of PACT: distinct domains for binding and activating PKR.

Authors:  G A Peters; R Hartmann; J Qin; G C Sen
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

3.  The C-terminal, third conserved motif of the protein activator PACT plays an essential role in the activation of double-stranded-RNA-dependent protein kinase (PKR).

Authors:  Xu Huang; Brian Hutchins; Rekha C Patel
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

4.  Inhibition of PACT-mediated activation of PKR by the herpes simplex virus type 1 Us11 protein.

Authors:  Gregory A Peters; David Khoo; Ian Mohr; Ganes C Sen
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

5.  Generation and comprehensive analysis of an influenza virus polymerase cellular interaction network.

Authors:  Lionel Tafforeau; Thibault Chantier; Fabrine Pradezynski; Johann Pellet; Philippe E Mangeot; Pierre-Olivier Vidalain; Patrice Andre; Chantal Rabourdin-Combe; Vincent Lotteau
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

6.  Evidence for a cytoplasmic microprocessor of pri-miRNAs.

Authors:  Jillian S Shapiro; Ryan A Langlois; Alissa M Pham; Benjamin R Tenoever
Journal:  RNA       Date:  2012-05-25       Impact factor: 4.942

7.  Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera.

Authors:  Zeyu Xiong; Yan Yan; Enli Liu; Richard T Silver; Srdan Verstovsek; Fan Yang; Hong Wang; Josef Prchal; Xiao-Feng Yang
Journal:  Clin Immunol       Date:  2006-11-17       Impact factor: 3.969

8.  Identification of the heparin-binding domains of the interferon-induced protein kinase, PKR.

Authors:  Stephen Fasciano; Brian Hutchins; Indhira Handy; Rekha C Patel
Journal:  FEBS J       Date:  2005-03       Impact factor: 5.542

9.  Dynamic changes in ribosome-associated proteome and phosphoproteome during deoxynivalenol-induced translation inhibition and ribotoxic stress.

Authors:  Xiao Pan; Douglas A Whitten; Curtis G Wilkerson; James J Pestka
Journal:  Toxicol Sci       Date:  2013-11-27       Impact factor: 4.849

10.  Inhibition of infection and replication of human herpesvirus 8 in microvascular endothelial cells by alpha interferon and phosphonoformic acid.

Authors:  Laurie T Krug; Veronika P Pozharskaya; Yimin Yu; Naoki Inoue; Margaret K Offermann
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.